Utilities Healthcare Sector

Merit Medical Systems

Market Cap: US$4.7b

Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.

Sotera Health

Market Cap: US$4.4b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Option Care Health

Market Cap: US$4.3b

Offers home and alternate site infusion services in the United States.

Akero Therapeutics

Market Cap: US$4.3b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Chartwell Retirement Residences

Market Cap: CA$6.0b

Chartwell is in the business of serving and caring for Canada's seniors, committed to its vision of Making People's Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.

Jyong Biotech

Market Cap: US$4.2b

A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Crinetics Pharmaceuticals

Market Cap: US$4.2b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

NewAmsterdam Pharma

Market Cap: US$4.2b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Kymera Therapeutics

Market Cap: US$4.1b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Hinge Health

Market Cap: US$3.9b

Focuses on scaling and automating the delivery of healthcare services.

Scholar Rock Holding

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

uniQure

Market Cap: US$3.8b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Viking Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

CorVel

Market Cap: US$3.7b

Provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.

TransMedics Group

Market Cap: US$3.7b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Mirum Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Lantheus Holdings

Market Cap: US$3.6b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Integer Holdings

Market Cap: US$3.5b

Operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally.

GeneDx Holdings

Market Cap: US$3.5b

A genomics company, provides genetic testing services.

Ligand Pharmaceuticals

Market Cap: US$3.5b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

EBOS Group

Market Cap: NZ$6.1b

Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand.

ADMA Biologics

Market Cap: US$3.5b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Alignment Healthcare

Market Cap: US$3.4b

Operates a consumer-centric healthcare platform for seniors in the United States.

1Life Healthcare

Market Cap: US$3.4b

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.

Soleno Therapeutics

Market Cap: US$3.4b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$3.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Zai Lab

Market Cap: US$3.4b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Telix Pharmaceuticals

Market Cap: AU$5.1b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

CG Oncology

Market Cap: US$3.3b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

SYNLAB

Market Cap: €2.8b

Provides medical diagnostic services and specialty testing services in Europe.

Mineralys Therapeutics

Market Cap: US$3.3b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

Procaps Group

Market Cap: US$3.2b

Develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe.

Apellis Pharmaceuticals

Market Cap: US$3.2b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Envista Holdings

Market Cap: US$3.2b

Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.

Amneal Pharmaceuticals

Market Cap: US$3.1b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Ansell

Market Cap: AU$4.7b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.